Development of hematin conjugated PLGA nanoparticle for selective cancer targeting
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Amin, Md. Lutful | - |
dc.contributor.author | Kim, Dami | - |
dc.contributor.author | Kim, SeJin | - |
dc.date.available | 2020-02-28T00:45:20Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2016-08-25 | - |
dc.identifier.issn | 0928-0987 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7997 | - |
dc.description.abstract | Targeted nanomedicine for cancer therapy has gained widespread popularity and is being extensively explored. Porphyrins have intrinsic tumor localizing ability and have been studied for photodynamic therapy. However, they have not been used as cancer targeting agents for nanomedicines. In this study, PLGA nanoparticles were formulated and an iron-containing blood porphyrin, hematin was conjugated to the surface of the nanoparticles to investigate selectivity towards cancer cell and cellular internalization. Hematin was previously shown to facilitate growth and proliferation of cancer cells. PLGA nanoparticles were characterized by FE-SEM, AFM, DLS, and Zeta potential analyzer. The conjugation of hematin was confirmed by FTIR. HeLa cells were used to study tumor selectivity and uptake. Hematin conjugated particles (zeta potential: - 15.19 mV) showed higher affinity towards the cancer cells than the control particles. The result indicated that the particles were internalized by heme carrier protein-1. Together these data suggest that hematin is a promising cancer targeting material for nanotherapeutics. (C) 2016 Elsevier B.V. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | - |
dc.subject | LOW-DENSITY LIPOPROTEIN | - |
dc.subject | PHOTODYNAMIC THERAPY | - |
dc.subject | PORPHYRIN LOCALIZATION | - |
dc.subject | ERYTHROLEUKEMIA-CELLS | - |
dc.subject | DRUG-DELIVERY | - |
dc.subject | HELA-CELLS | - |
dc.subject | TUMOR | - |
dc.subject | NANOTECHNOLOGY | - |
dc.subject | HEME | - |
dc.subject | TRANSFERRIN | - |
dc.title | Development of hematin conjugated PLGA nanoparticle for selective cancer targeting | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000382532100017 | - |
dc.identifier.doi | 10.1016/j.ejps.2016.05.029 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, v.91, pp.138 - 143 | - |
dc.identifier.scopusid | 2-s2.0-84975796857 | - |
dc.citation.endPage | 143 | - |
dc.citation.startPage | 138 | - |
dc.citation.title | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | - |
dc.citation.volume | 91 | - |
dc.contributor.affiliatedAuthor | Amin, Md. Lutful | - |
dc.contributor.affiliatedAuthor | Kim, Dami | - |
dc.contributor.affiliatedAuthor | Kim, SeJin | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | PLGA nanoparticle | - |
dc.subject.keywordAuthor | Hematin | - |
dc.subject.keywordAuthor | Drug delivery | - |
dc.subject.keywordAuthor | Targeted nanoparticle | - |
dc.subject.keywordAuthor | Surface modification | - |
dc.subject.keywordPlus | LOW-DENSITY LIPOPROTEIN | - |
dc.subject.keywordPlus | PHOTODYNAMIC THERAPY | - |
dc.subject.keywordPlus | PORPHYRIN LOCALIZATION | - |
dc.subject.keywordPlus | ERYTHROLEUKEMIA-CELLS | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | HELA-CELLS | - |
dc.subject.keywordPlus | TUMOR | - |
dc.subject.keywordPlus | NANOTECHNOLOGY | - |
dc.subject.keywordPlus | HEME | - |
dc.subject.keywordPlus | TRANSFERRIN | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.